Faison Warachal E, Harrell P Grace, Semel David
Medical Affairs, Internal Medicine, Pfizer Inc., 235 E. 42nd Street New York, New York, NY 10017, USA.
Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA.
Healthcare (Basel). 2021 Oct 22;9(11):1421. doi: 10.3390/healthcare9111421.
The study of disparities across diverse populations regarding the health and treatment of patients with osteoarthritis (OA) is recognized as a priority for investigation and action by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and the American Academy of Orthopedic Surgeons (AAOS). OA is a common condition that increases with age, but with prevalence generally similar across racial and ethnic groups. However, disparities in the treatment of OA among racial, ethnic, and socioeconomic groups are well-documented and continue to rise and persist. The reasons are complex, likely involving a combination of patient, provider, and healthcare system factors. Treatment disparities among these different populations have an impact on clinical outcomes, healthcare, and productivity, and are projected to increase significantly with the growing diversity of the United States population. The aim of this short review is to summarize studies of racial, ethnic, and socioeconomic disparities among patients with OA in the United States, with a focus on prevalence, treatment utilization, and clinical and economic outcomes.
美国国立关节炎、肌肉骨骼和皮肤病研究所（NIAMS）及美国骨科医师学会（AAOS）认为，研究不同人群中骨关节炎（OA）患者的健康状况和治疗差异是调查和行动的重点。OA是一种常见疾病，其发病率随年龄增长而增加，但在不同种族和族裔群体中的患病率通常相似。然而，种族、族裔和社会经济群体在OA治疗方面的差异有充分记录，且仍在上升并持续存在。原因很复杂，可能涉及患者、医疗服务提供者和医疗保健系统等多种因素。这些不同人群之间的治疗差异会对临床结果、医疗保健和生产力产生影响，并且预计随着美国人口多样性的增加，差异还会显著扩大。本简短综述的目的是总结美国OA患者在种族、族裔和社会经济方面差异的研究，重点关注患病率、治疗利用率以及临床和经济结果。
